Is combined androgen blockade with bicalutamide cost-effective compared with combined androgen blockade with flutamide?

Urology

Volumn 66, Issue 4, 2005, Pages 835-839

  Ramsey, Scott ^b   Veenstra, David ^b   Clarke, Lauren ^b   Gandhi, Sanjay ^b   Hirsch, Mark ^b   Penson, David ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BICALUTAMIDE; FLUTAMIDE; GONADORELIN AGONIST; LOPERAMIDE;

ARTICLE; CANCER SURVIVAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DIARRHEA; DISEASE SEVERITY; DRUG COST; DRUG EFFICACY; DRUG WITHDRAWAL; FOLLOW UP; HEMATURIA; HUMAN; MALE; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY ADJUSTED LIFE YEAR; TREATMENT OUTCOME;

ANDROGEN ANTAGONISTS; ANILIDES; ANTINEOPLASTIC AGENTS; COST-BENEFIT ANALYSIS; DRUG THERAPY, COMBINATION; FLUTAMIDE; HUMANS; MALE; PROSTATIC NEOPLASMS;

EID: 26644469542     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2005.04.028     Document Type: Article

References (9)

1. P.F. Schellhammer, R. Sharifi, N.L. Block Casodex Combination Study Group Clinical benefits of bicalutamide compared with flutamide in combined androgen blockade for patients with advanced prostatic carcinoma final report of a double-blind, randomized, multicenter trial Urology 50 1997 330 336
2. A.M. Bayoumi, A.D. Brown, A.M. Garber Cost-effectiveness of androgen suppression therapies in advanced prostate cancer J Natl Cancer Inst 92 2000 1731 1739
3. S.H. Taplin, W. Barlow, N. Urban Stage, age, comorbidity, and direct costs of colon, prostate, and breast cancer care Nat Cancer Inst 87 1995 417 426
4. P. Ubel What is the price of life and why doesn't it rise with the rate of inflation? Arch Intern Med 163 2003 1638 1641
5. B.E. Hillner, J.D. Roberts Role of perspective and other uncertainties in cost-effectiveness assessments in advanced prostate cancer J Natl Cancer Inst 92 2000 1704 1706
6. L. Klotz, P. Schellhammer, K. Carroll A re-assessment of the role of combined androgen blockade for advanced prostate cancer BJU Int 93 2004 1177 1182
7. Prostate Cancer Trialists' Collaborative Group Maximum androgen blockade in advanced prostate cancer an overview of the randomised trials Lancet 346 2000 1491 1498
8. D.J. Samson, J. Seidenfeld, B. Schmitt Systematic review and meta-analysis of monotherapy compared with combined androgen blockade for patients with advanced prostate carcinoma Cancer 95 2002 361 376
9. D.F. Penson, S.B. Ramsey, D. Veenstra The cost-effectiveness of combined androgen blockade with bicalutamide and LHRH agonist in men with metastatic prostate cancer J Urol 174 2005 547 552